Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks
OTCMKTS:ENZN

Enzon Pharmaceuticals 8/14/2025 Earnings Report

Enzon Pharmaceuticals logo
$0.09 +0.01 (+7.40%)
As of 01:27 PM Eastern
ProfileEarnings History

Enzon Pharmaceuticals EPS Results

Actual EPS
-$0.02
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Enzon Pharmaceuticals Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Enzon Pharmaceuticals Announcement Details

Quarter
Date
8/14/2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Enzon Pharmaceuticals' next earnings date is estimated for Monday, November 3, 2025, based on past reporting schedules.

Conference Call Resources

Enzon Pharmaceuticals Earnings Headlines

Enzon Pharmaceuticals, Inc. (ENZN) - Yahoo Finance
June 24, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/quote/ENZN/financials/
Enzon Pharmaceuticals (ENZN) Merges with Viskase Companies
June 21, 2025  |  gurufocus.comhttps://www.gurufocus.com/news/2938181/enzon-pharmaceuticals-enzn-merges-with-viskase-companies
Think you missed gold’s boom? Think again
If you've been watching gold's historic run and wondering if it's too late… I've got good news. Because there's a $15 fund tied directly to gold's surge that's still paying massive income… Up to 64% annually — with payouts every 30 days.tc pixel
August 26 at 2:00 AM  |  Investors Alley (Ad)
Enzon Pharmaceuticals, Inc: Enzon and Viskase Enter into Merger Agreement
June 21, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-06/65719249-enzon-pharmaceuticals-inc-enzon-and-viskase-enter-into-merger-agreement-399.htm
Enzon to merge with Viskase in all stock deal
June 21, 2025  |  msn.comhttps://www.msn.com/en-us/money/companies/enzon-to-merge-with-viskase-in-all-stock-deal/ar-AA1H9Qq3
Enzon and Viskase Enter into Merger Agreement
June 20, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/06/21/3102982/0/en/enzon-and-viskase-enter-into-merger-agreement.html
See More Enzon Pharmaceuticals Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Enzon Pharmaceuticals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Enzon Pharmaceuticals and other key companies, straight to your email.

About Enzon Pharmaceuticals

Enzon Pharmaceuticals (OTCMKTS:ENZN), Inc., together with its subsidiaries, does not have significant operations. Previously, the company marketed its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.

View Enzon Pharmaceuticals Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles